[Radiation therapy of lymphogranulomatosis: Results under special consideration of recurrences in the early stages (author's transl)].
Absolute 5-year survival rates from 105 primarily irradiated patients with Hodgkin's disease amount to 79% for Stage I and to 88% for Stage II cases. Out of this collective, the patients free from recurrences during 5 years come to a rate of 75% in Stage I and 41% in Stage II. In 37 patients, recurrences were observed, the causes of which are being examined. From the site of the recurrences conclusions may be drawn in view of an improved treatment.
D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D002675:Child, Preschool; D005260:Female; D006689:Hodgkin Disease / Q000532:radiotherapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local; D011379:Prognosis; D011879:Radiotherapy Dosage; D013997:Time Factors
Zur Strahlentherapie der Lymphogranulomatose. Ergebnisse unter besonderer Berücksichtigung der Rezidive in den frühen Stadien.